Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The persistence of substantial fetal hemoglobin production into adulthood, usually associated with hemoglobinopathies due to mutations in the alpha and/or beta chain of hemoglobin.
Biomarker and diagnostic research for hereditary persistence of fetal hemoglobin has been reported in the published literature.
No clinical trials have been registered for hereditary persistence of fetal hemoglobin.
142 publications have been identified in PubMed for hereditary persistence of fetal hemoglobin. Research spans Review / Meta-Analysis (34%), Basic Science / Preclinical (20%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 48 | 34% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:51 AM UTC
Laboratory research
29 |
20% |
Disease patterns and progression | 26 | 18% |
Clinical study results | 12 | 8% |
New treatment approaches | 10 | 7% |
Patient case studies | 9 | 6% |
Testing and diagnosis research | 7 | 5% |
Other research | 1 | 1% |
Pellicani S (2026). [PMID: 42116066](https://pubmed.ncbi.nlm.nih.gov/42116066/). *Ital J Pediatr*. [Case Report / Case Series]
Singha K (2026). [PMID: 41996320](https://pubmed.ncbi.nlm.nih.gov/41996320/). *PLoS One*. [Epidemiology / Natural History]
Marco E (2026). [PMID: 40994008](https://pubmed.ncbi.nlm.nih.gov/40994008/). *Mol Ther*. [Gene Therapy / Novel Therapeutics]
Taneera J (2026). [PMID: 40785179](https://pubmed.ncbi.nlm.nih.gov/40785179/). *Curr Cardiol Rev*. [Review / Meta-Analysis]
Abu Za'ror YSM (2026). [PMID: 42136897](https://pubmed.ncbi.nlm.nih.gov/42136897/). *Mediterr J Hematol Infect Dis*. [Review / Meta-Analysis]
Frangoul H (2026). [PMID: 41931048](https://pubmed.ncbi.nlm.nih.gov/41931048/). *N Engl J Med*. [Clinical Trial Publication]
Theocharaki K (2026). [PMID: 41115240](https://pubmed.ncbi.nlm.nih.gov/41115240/). *Blood Adv*. [Epidemiology / Natural History]
Kwiatkowski JL (2026). [PMID: 41525466](https://pubmed.ncbi.nlm.nih.gov/41525466/). *Blood*. [Clinical Trial Publication]
Shen Y (2026). [PMID: 41347631](https://pubmed.ncbi.nlm.nih.gov/41347631/). *Adv Sci (Weinh)*. [Gene Therapy / Novel Therapeutics]
Cheng AN (2026). [PMID: 41919270](https://pubmed.ncbi.nlm.nih.gov/41919270/). *Ther Adv Rare Dis*. [Review / Meta-Analysis]